| Literature DB >> 31965157 |
Cristina Y Zamora1,2, Elizabeth M Ward1,3, Jemila C Kester4, Wen Li Kelly Chen4, Jason G Velazquez4, Linda G Griffith4,5, Barbara Imperiali1,2.
Abstract
An in vitro gut-immune co-culture model with apical and basal accessibility, designed to more closely resemble a human intestinal microenvironment, was employed to study the role of the N-linked protein glycosylation pathway in Campylobacter jejuni pathogenicity. The gut-immune co-culture (GIC) was developed to model important aspects of the human small intestine by the inclusion of mucin-producing goblet cells, human enterocytes and dendritic cells, bringing together a mucus-containing epithelial monolayer with elements of the innate immune system. The utility of the system was demonstrated by characterizing host-pathogen interactions facilitated by N-linked glycosylation, such as host epithelial barrier functions, bacterial invasion and immunogenicity. Changes in human intestinal barrier functions in the presence of 11168 C. jejuni (wildtype) strains were quantified using GICs. The glycosylation-impaired strain 11168 ΔpglE was 100-fold less capable of adhering to and invading this intestinal model in cell infectivity assays. Quantification of inflammatory signaling revealed that 11168ΔpglE differentially modulated inflammatory responses in different intestinal microenvironments, suppressive in some but activating in others. Virulence-associated outer membrane vesicles produced by wildtype and 11168ΔpglE C. jejuni were shown to have differential composition and function, with both leading to immune system activation when provided to the gut-immune co-culture model. This analysis of aspects of C. jejuni infectivity in the presence and absence of its N-linked glycome is enabled by application of the gut-immune model, and we anticipate that this system will be applicable to further studies of C. jejuni and other enteropathogens of interest.Entities:
Keywords: zzm321990 Campylobacter jejunizzm321990 ; N-linked glycosylation; bacterial virulence; enteropathogens; intestinal models of infection
Year: 2020 PMID: 31965157 PMCID: PMC7234929 DOI: 10.1093/glycob/cwz105
Source DB: PubMed Journal: Glycobiology ISSN: 0959-6658 Impact factor: 4.313